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Abstract
Background: The prozone effect (or high doses-hook phenomenon) consists of false-negative or
false-low results in immunological tests, due to an excess of either antigens or antibodies. Although
frequently cited as a cause of false-negative results in malaria rapid diagnostic tests (RDTs),
especially at high parasite densities of Plasmodium falciparum, it has been poorly documented. In this
study, a panel of malaria RDTs was challenged with clinical samples with P. falciparum
hyperparasitaemia (> 5% infected red blood cells).
Methods: Twenty-two RDT brands were tested with seven samples, both undiluted and upon 10
×, 50 × and 100 × dilutions in NaCl 0.9%. The P. falciparum targets included histidine-rich protein-
2 (HRP-2, n = 17) and P. falciparum-specific parasite lactate dehydrogenase (Pf-pLDH, n = 5). Test
lines intensities were recorded in the following categories: negative, faint, weak, medium or strong.
The prozone effect was defined as an increase in test line intensity of at least one category after
dilution, if observed upon duplicate testing and by two readers.
Results: Sixteen of the 17 HRP-2 based RDTs were affected by prozone: the prozone effect was
observed in at least one RDT sample/brand combination for 16/17 HRP-2 based RDTs in 6/7
samples, but not for any of the Pf-pLDH tests. The HRP-2 line intensities of the undiluted sample/
brand combinations with prozone effect (n = 51) included a single negative (1.9%) and 29 faint and
weak readings (56.9%). The other target lens (P. vivax-pLDH, pan-specific pLDH and aldolase) did
not show a prozone effect.
Conclusion: This study confirms the prozone effect as a cause of false-negative HRP-2 RDTs in
samples with hyperparasitaemia.
Background
Malaria rapid diagnostic tests (RDTs) are lateral flow
immunochromatographic tests that detect Plasmodium
antigens by antibody-antigen interactions on a nitrocellu-
lose test strip. Capillary or venous blood and a lysis buffer
are added to the strip: if present in the sample, the Plasmo-
dium antigen is bound to a detection antibody. This detec-
tion antibody is usually a monoclonal mouse-antibody
conjugated to a signal, mostly colloidal gold. The antigen-
detection antibody-conjugate complex diffuses further
across the strip until it is bound to a second antibody: this
so-called capture antibody reacts to another epitope of the
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row section of the strip, the conjugated signal is concen-
trated and becomes visible as a cherry-red or purple
colored line. The excess of detection antibody-conjugate
that was not bound by the antigen and the capture anti-
body moves further until it is bound to a goat anti-mouse
antibody, thereby generating a control line. The Plasmo-
dium antigens targeted by RDTs include those specific to
Plasmodium falciparum (histidine-rich protein-2 (HRP-2)
and P. falciparum-specific parasite lactate dehydrogenase
(Pf-pLDH)), the antigen specific to Plasmodium vivax (P.
vivax-specific parasite lactate dehydrogenase, Pv-pLDH)
and the antigens common to P. falciparum, P. vivax, Plas-
modium ovale and Plasmodium malariae (pan-species para-
site lactate dehydrogenase (pan-pLDH) and aldolase).
The RDT strip is produced either as a simple dipstick or
fixed in a cassette or cardboard format. RDTs combine a
control line with one or more antigen detecting test lines:
those with a single test line are named two band RDTs,
those with two and three antigen test lines are known as
three-band and four-band RDTs respectively.
The use of malaria rapid diagnostic tests is expanding,
both in endemic and non-endemic settings [1]. In 2007,
more than 70 million RDTs have been procured [2] and in
many endemic countries, RDTs are now being rolled out
as the instrument of choice for parasite-based malaria
diagnosis and patient management at all levels of health
care [3]. Under controlled conditions, RDTs have shown
sensitivities close to 100% for the detection of P. falci-
parum, the most life-threatening species. However, there
are still false-negative results: most of them occur at low
parasite densities (< 100 asexual parasites/μl or < 0.002%
of red blood cells infected), but others occur at high para-
site densities, in particular at hyperparasitaemia, defined
by the World Health Organization (WHO) as infections
with > 5% of red blood cells infected [4]. Mostly, the latter
are ascribed to genetic variations of the HRP-2 [3-5], but
the prozone effect is also cited as an explanation [1,6-10].
The prozone effect (also known as high dose-hook phe-
nomenon) is defined as false-negative or false-low results
in immunological reactions, due to an excess of either
antigens or antibodies [11]. It occurs particularly in one-
step immunoassays, such as agglutination tests, for which
serial dilutions are advised to trace the effect [12]. In the
case of hyperparasitaemia in RDTs, high antigen concen-
trations will block all available binding sites of both the
detection and the capture antibodies, thereby preventing
the binding of the antigen-detection antibody-conjugate
complex to the capture antibody, with failure of signal
generation. Simple dilution of the sample will correct this
effect. Despite frequently cited in literature on RDTs, there
is only a single original report in which the prozone effect
in RDT is unequivocally demonstrated by appearance of
the test line upon dilution of the sample [13]. Since atten-
tion was drawn to this effect by a recent case (see below)
presented at the Institute of Tropical Medicine (ITM), a
panel of RDTs was challenged to clinical samples with P.
falciparum hyperparasitaemia.
Case description
An EDTA-blood sample of a 69-year old male patient,
returning from Nigeria was submitted to the reference lab-
oratory of ITM. The referring laboratory had made the
microscopic diagnosis of P. falciparum malaria with a par-
asite density of 27.5%. However, they were puzzled about
the result of the RDT, which they performed in conjunc-
tion to microscopy: in addition to the control line, the test
showed a clear pan-Plasmodium aldolase line but there
was no HRP-2 line visible. According to the instructions of
the manufacturer, this combination points to the diagno-
sis of non-falciparum malaria.
Upon receipt of the sample, the diagnosis of P. falciparum
was confirmed as well as the parasite density. The sample
was tested with the usual panel of RDTs used in ITM. The
BinaxNow® (Binax, Scarborough, Maine, U.S.) and the SD
FK60 Malaria Ag P. falciparum/Pan (Standard Diagnostics,
Hagal-Dong, Korea) showed faint and barely distinguish-
able HRP-2 lines in combination with clear control and
pan-Plasmodium lines (aldolase and pan-pLDH respec-
tively). The Optimal-IT test (DiaMed AG, Cressier s/
Morat, Switzerland) showed clear lines for both Pf-pLDH
and pan-pLDH. A 10 × dilution of the EDTA-blood in
NaCl 0.9% resulted for both the BinaxNow® and the SD
FK60 tests in clearly distinguishable HRP-2 lines of inten-
sities equal to the control line. When doubled volume of
the undiluted blood was applied to the sample pad, the
HRP-2 line was still visible as a faint line in the SD FK60,
but was no longer visible in the BinaxNow® test. It was
concluded that the prozone effect was the cause of the
false-low and false-negative test line intensities.
Methods
Patients' samples
In this study EDTA-blood samples obtained from interna-
tional travellers presenting at the outpatient clinic of ITM,
Antwerp, Belgium, as well as samples submitted by Bel-
gian laboratories to ITM in its functions as the National
Reference Centre were used. Part of them were fresh sam-
ples, the other samples had been stored at -70°C till anal-
ysis. For all samples, the diagnosis of malaria was made by
microscopy and confirmed with species-specific PCR as
previously described [14]. Parasite density was assessed by
counting the number of asexual parasites against 200
white blood cells in a thick film, and converting this value
to parasites/μl using the actual count or the standard of
8,000 white blood cell/μl [15]. For the purpose of this
study, the more convenient parasite density as expressed
in % of infected red blood cells was applied, therebyPage 2 of 7
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parasitized [15]. P. falciparum-infected samples with
hyperparasitaemia were selected and a sample with para-
site density of 0.1% (5,000/μl) was used as a control sam-
ple.
Malaria rapid diagnostic tests
Malaria RDTs chosen were those included in the WHO list
of RDT manufacturers with adequate evidence of good
manufacturing practice available online [16] and assess-
ment was focused on those products available in cassette
and folded card box format. In addition to this list, other
RDTs available on the international market were ran-
domly included. In view of the wide lot-to-lot variations
and the ever changing composition of RDTs, it was
decided not to display the individual RDT brand names,
in line with a similar study that compared RDT heat sta-
bilities [17].
Tests were performed according to the instructions of the
manufacturer, except that samples were loaded with a
pipette (Finnpipette, Helsinki, Finland) instead of the
transfer device supplied by the manufacturer. In case the
control line did not appear the result was interpreted as
invalid and the test was repeated. In order to qualify the
test line intensities, a scoring system of five categories was
used: none (no line visible), faint (barely visible line),
weak (paler than the control line), medium (equal to the
control line) or strong (stronger than the control line)
[14]. All tests were carried out in duplicate. Readings were
performed by two readers at daylight assisted by a stand-
ard electric bulb, and within and not beyond the pre-
scribed delay after application of the sample and buffer.
Tests were performed on undiluted samples as well as on
samples diluted 10 ×, 50 × or 100 × in saline solution
(NaCl) 0.9%.
Test outcomes and definitions
For the results of test line intensities, consensus readings
were considered, i.e. the line intensities most frequently
scored in the duplicate test/two readers' combination. The
prozone effect was defined as an increase in test line inten-
sity of at least one category after dilution, if observed
upon duplicate testing and by two readers.
Statistical analysis
Inter-reader reliability for line intensities was calculated as
percentage agreements and kappa values. Reproducibility
was expressed as the consistency of line intensity readings
for both readers and upon repeating the tests.
Ethical review
The study was reviewed and approved by the Institutional
Review Board of ITM and by the Ethical Committee of
Antwerp University, Belgium.
Results
Collection of samples and RDTs
Seven samples with hyperparasitaemia were elected, their
parasite densities are listed in Additional file 1. Six sam-
ples had been stored at -70°C for a period of three to 96
months, one was assessed freshly. They were all obtained
in patients returning from sub-Saharan Africa. Twenty-
two brands of RDTs were collected, 17 of them targeted P.
falciparum by detecting HRP-2, the other five detected Pf-
pLDH (two of which produced by the same company).
The RDT brands included three two-band tests, 15 three-
band tests and four four-band tests. The antigens targeting
all four common species comprised pan-pLDH (n = 16)
and aldolase (n = 2). Fourteen RDTs had CE mark compli-
ance, 14 were included in the WHO list and one is author-
ized for use in the United States (US FDA approved).
Inter-reader reliability and reproducibility
Inter-reader reliability for P. falciparum test line intensities
was high, with 86.7% agreement and a kappa value of
0.79, and discrepancies limited to one category of line
intensity (e.g. line intensity read as weak by reader 1 and
as medium (but not strong) by reader 2). Upon duplicate
testing, 82.5% and 80.3% of 319 P. falciparum line inten-
sities were identically read by each of both readers respec-
tively. For the non-falciparum test line intensities (pan-
pLDH and aldolase), agreement and kappa value for line
intensities between readers was 88.2% and 0.84 respec-
tively. These differences had no effect on the numbers of
samples with prozone effect. All 51 sample/brand combi-
nations, (six samples for 12 brands) with prozone effect
showed the effect as defined for both observers, and no
additional cases were suggested by the observation of only
a single observer.
Prozone effect
For the Pv-pLDH, pan-pLDH and aldolase lines, there
were 136 sample/brand combinations tested: in 51
(36.7%) of them (representing 11/14 RDTs), the 10 ×
diluted samples showed weaker line intensities as com-
pared to the undiluted samples. The control lines were
well visible in all cases, except in four invalid brand/sam-
ple combinations for a single brand (RDT nr. 4, Addi-
tional file 1). For the P. falciparum lines, there was a clear
difference between HRP-2 lines and Pf-pLDH lines. For
the control sample of parasite density of 0.1%, all but one
RDTs showed medium or strong line intensities upon
undiluted testing; RDT nr.12 showed a weak HRP-2 line
intensity. When assessed with the samples with hyperpar-
asitaemia, the five three-band tests targeting Pf-pLDH did
not show a prozone effect. For one RDT, there were two
samples that showed a decrease in Pf-pLDH line intensity
at the 10 × dilution; the other combinations did not
change line intensity upon dilution. By contrast, the pro-
zone effect was observed for at least one sample in all, butPage 3 of 7
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RDT brand that did not display a prozone effect was RDT
nr. 12, which showed a decrease in test line intensity upon
10 × dilution. The prozone effect tended to occur more
frequently in particular brands and samples and was not
directly related to the parasite count: for instance, the sam-
ple with 11.6% parasite density showed the prozone effect
for all but one brand, whereas the sample with 35.0% par-
asite density did so for 8/21 brands tested. There was no
difference in prozone effect between RDTs that were CE-
marked, FDA approved or WHO-listed and those that
were not. In terms of test line intensities, the distribution
for the undiluted sample/brand combinations with pro-
zone effect (n = 51) was as follows: a single (1.9%) nega-
tive reading, four (7.8%) faint readings, three (5.9%)
either faint or weak readings (depending on the observer),
22 (43.1%) weak readings and 21 (41.2%) medium read-
ings. This means that for a total of 29 (56.9%) of sample/
brand combinations (in 12/17 RDTs) with the prozone
effect, the undiluted sample showed a faint or weak HRP-
2 line. Maximum (strong) line intensities were obtained
at a 10 × dilution for 28 out of 51 sample/brand combi-
nations. For the remaining 23 combinations there was
enough additional material for 16 combinations to per-
form 50 × or 100 × dilutions, in which 12 and four
reached respectively the strong line intensity.
Discussion
RDTs offer great potential for the timely and accurate diag-
nosis of malaria, thereby leading to prompt and appropri-
ate treatment. They have found their place in both
malaria-endemic and non-endemic settings. In endemic
settings, they offer parasite-based diagnosis in the absence
of competent laboratory infrastructures as they can be car-
ried out by non-specialized health care workers [18,19].
In non-endemic settings, where microscopic expertise is
lacking due to low incidence, they are used as adjunct to
microscopy especially outside office hours but also as
bedside point of care tests [20,21]. In addition, RDTs are
marketed for self-use by travellers [10]. In this study, RDTs
were challenged with a panel of clinical samples with P.
falciparum hyperparasitaemia. The prozone effect was
observed for the HRP-2 test lines in 16/17 RDTs, and was
consistent among the two observers. None of the P. falci-
parum specific Pf-LDH lines (tested in five RDTs) showed
the prozone effect, nor did any of the pLDH and aldolase
lines.
The present study has its limitations. A calibrated pipette
was used instead of the manufacturer's transfer device,
thereby bypassing a possible error of the kit's application
system. Next, in reference to the original report [13], dilu-
tions were made in NaCl 0.9% and not, for instance, in
the kit's diluent. Also, this evaluation was performed in a
reference setting, with expert technicians who are used to
evaluate RDTs and who are trained not to disregard faint
positive lines, thereby possibly underestimating the inci-
dence of the prozone effect as compared to field settings.
Despite these limitations, this study documents the pro-
zone effect among the present panel of RDTs according to
stringent and reproducible criteria.
Most reviews and leading authorities point to the possibil-
ity of the prozone effect in RDTs [1,8,22,23], but there is
only a single original report describing this effect in a
RDT: in 1999, Risch and co-workers described a patient
returning from Yemen, with a P. falciparum infection at a
parasite density of 30%. The RDT they used (ICT Malaria,
Pf, ICT, Australia - a HRP-2 targeted two band test which
is no longer marketed) showed no test line for the undi-
luted sample, but a clearly distinguishable line at 10 ×
dilution in NaCl 0.9% [13]. Another report described, as
part of a prospective study, a patient returning from The
Gambia, with microscopic diagnosis of P. falciparum at a
parasite density of 31%. For the BinaxNow® Malaria Pf/Pv
test, the authors reported observations identical to those
presently described, i.e. a faint HRP-2 line but a strong P.
vivax-test line (the latter line representing in fact pan-Plas-
modium LDH reactivity). Although the authors described
this effect in full detail and added a picture, they did not
refer to the possibility of the prozone effect and did not
carry out dilution studies. In addition to these reports on
hyperparasitaemia there are rare but consistent reports of
unexplained failures of mainly HRP-2 RDTs at parasite
densities in the intermediate ranges (e.g. between 10,000/
μl and 100,000/μl (0.2% and 2% respectively
[1,9,12,14,24-31]). The most frequently cited explanation
for these failures is the presence of HRP-2 polymorphisms
[1,3,5,6,22], although the polymorphisms that are less
likely to be picked up by RDTs are geographically con-
fined to the Asia-Pacific region whereas many of the fail-
ures occurred in field settings in Africa [5]. The prozone
effect in these samples can be an alternative explanation,
but at present samples with intermediate parasite densi-
ties were not included in this study.
The observation that, among the presently studied RDTs,
HRP-2 brands, but not Pf-pLDH brands are subject to the
prozone effect is of interest but remains unexplained.
Compared to the Pf-pLDH based RDTs, HRP-2 based
RDTs also tend to be more affected by the rheumatoid fac-
tor, giving rise to false-positive results [32,33]. In addi-
tion, the absence of the prozone effect in the pan-pLDH
and aldolase lines is in line with this observation.
Although the prozone effect was observed in none of the
currently tested Pf-pLDH based RDTs, further research
should be done to confirm the absence of the prozone
effect in other Pf-pLDH RDTs. It is also of note that the
prozone effect did not occur in clear relation to the para-
site density: this may be due to different factors affectingPage 4 of 7
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sequestration of the parasites, variations in the produc-
tion of antigen production during the cycle as well as by
strain differences [34,35].
In the present study, only a single sample/brand combina-
tion showed complete absence of HRP-2 test line and four
samples showed faint line intensities, representing only 5/
51 (9.8%) of the tests affected by prozone. However, three
additional tests were read as faint by one out of two
observers. Further, it should be stressed that the present
readings were made by experienced technicians who were
trained to interpret faint, weak and medium tests lines,
and who were working in reference conditions. By con-
trast, misinterpretation of faint lines as negative results is
a common mistake made by inexperienced staff, travellers
and community health care workers both in endemic and
non-endemic settings [18,19,21,36] In endemic settings,
readings of RDTs are frequently performed in unfavorable
light conditions during evening and night shifts [37].
Finally it should be noted that the four faint lines all
occurred in two of the three two-band RDTs that are fre-
quently used in field setting.
The consequences of a falsely negative interpretation are
serious: in the case of two-band tests, the diagnosis of
malaria may be missed, and in the case of a three-band
test, an infection with P. falciparum will be erroneously
diagnosed as a non-falciparum species. Of note is the
observation with the submitted sample described in the
case report: when the double sample volume was applied,
there was complete absence of the HRP-2 test line in one
of the RDTs. This may also cause problems in field set-
tings, where there is a tendency to apply more than the
required sample volume [38,39].
Although among the presently challenged panel the pro-
zone effect was common, it is yet unclear how frequent it
occurs in routine diagnosis. As to the use of RDTs in low
resource settings, it is of note that all three tested HRP-2
two-band brands are used in high numbers by non-gov-
ernmental organizations in emergency relief operations
and are presently introduced in national malaria control
programs [3]. For example, the 3,000,000 RDT tests pro-
vided in 2008 by the Global Fund to Fight AIDS, Tubercu-
losis and Malaria, all belonged to these three brands [40].
The impact of prozone for these three HRP-2 two-band
brands is of concern as it occurred in two, four and six
samples respectively. Moreover, the test line intensities
obtained with undiluted samples were faint or weak in
four and six samples respectively.
In setting of ITM, samples with hyperparasitaemia
occurred at a frequency of 5.5% among 200 single-patient
P. falciparum samples processed over a 23-month period
(May 2007-April 2009). Further study, including incident
reporting and large-scale prospective testing, should be
performed both in the endemic and the non-endemic set-
tings in order to have reliable estimates of the prozone
effect as a cause of false-negative RDT results.
False-negative results at low parasite densities can be
countered by diagnostic algorithms prescribing repeat or
serial testing when malaria is suspected and the initial
RDT test result is negative [6,12]. By contrast, false-nega-
tive results in hyperparasitaemia are to be corrected
immediately. What can be done to prevent or overcome
the prozone effect? First, it is imperative to train end-users
of RDTs in correctly reading and interpreting faint and
weak test lines and emphasizing that the appearance of
the control line does not guarantee control of all aspects
of RDT test performance. Second, for non-endemic set-
tings, previous recommendations to perform competent
microscopy in parallel to the RDTs should be emphasized
[1]: an instructed lab technician, even when not expert in
malaria and not able to perform species identification, is
expected to find and recognize Plasmodium parasites in
samples with hyperparasitaemia and even in samples with
lower parasite densities. If microscopy is not possible or
feasible, one could consider having a RDT targeting Pf-
pLDH at the hand, thereby assuming that Pf-pLDH tests
are not prone to the prozone effect. Suspected samples
should be retested on a 10 × and if needed a subsequent
50 × dilution of the sample, with dilutions made in NaCl
0.9%, pending further research on the most appropriate
diluents. On the regulatory level, it would be interesting
to test all marketed RDTs for their susceptibility to the
prozone effect.
Conclusion
In conclusion, the study demonstrated the prozone effect
for the detection of P. falciparum in 16/17 HRP-2 based
RDTs. The effect did not occur in the five Pf-pLDH RDTs
neither in the pan-pLDH and aldolase lines. The HRP-2
line intensities in undiluted samples were negative in a
single sample/brand combination and displayed faint or
weak line intensities in nearly 60% of sample/brand com-
binations; therefore, the prozone effect is expected to have
consequences in diagnosis and patient care both in
endemic and non-endemic settings. Dilutions of 10 × and
if needed 50 × should be made to detect this effect, and
microscopy and/or a Pf-pLDH RDT can be done when the
prozone effect is suspected. Further research should con-
firm the absence of the prozone effect in other Pf-pLDH
targeted RDTs and assess the incidence of the prozone
effect in false-negative results in both endemic and non-
endemic settings.Page 5 of 7
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